![](https://news.europawire.eu/wp-content/uploads/2016/06/medtronic-logo-144x144.jpg)
Secondary Analyses Presented at Cardiostim 2016 Highlight Positive, Real-World Patient Outcomes DUBLIN AND NICE, FRANCE, 10-Jun-2016 — /EuropaWire/ — Medtronic plc (NYSE: MDT) today announced findings from the secondary analyses of theFIRE AND ICE clinical trial that demonstrate significantly fewer repeat … Read the full press release